Camille Chakiba

Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy

Stéphanie Hoppe, M. Rainfray, Marianne Fonck et al. · Journal of Clinical Oncology · 2013 · 231 citations

Medicine, Geriatric Medicine, Oncology +17

Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms

Sabrina Croce, Isabelle Hostein, Teri A. Longacre et al. · Modern Pathology · 2018 · 135 citations · Full text

Medicine, Oncology, Pathology +16

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study

Hervé Bonnefoi, William Jacot, Mahasti Saghatchian et al. · Annals of Oncology · 2014 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor−Positive Recurrent or Metastatic Endometrial Cancer

Pierre‐Etienne Heudel, Jean‐Sébastien Frenel, Cécile Dalban et al. · JAMA Oncology · 2022 · 79 citations · Full text

Medicine, Oncology, Pharmacology +16